رجوع
نطاق اليوم
KWD 24.95
KWD 25.70
نطاق 52 أسبوعًا
KWD 11.51
KWD 29.80
حجم التداول
86,755
متوسط 50 يوم / 200 يوم
KWD 26.82
/
KWD 23.56
الإغلاق السابق
KWD 25.70
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -12.3 | 0.3 |
| P/B | 6.2 | 2.9 |
| ROE % | -41.2 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 45.600
+80.0%
Low: KWD 38.000
High: KWD 60.000
ربحية السهم المستقبلية
-KWD 3.096
الإيرادات المقدّرة
1.3 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 1.294
KWD 1.294 – KWD 1.294
|
570 M | 4 |
| FY2028 |
-KWD 1.064
-KWD 3.243 – KWD 0.577
|
260 M | 6 |
| FY2027 |
-KWD 2.536
-KWD 3.548 – -KWD 1.774
|
61 M | 8 |
النقاط الرئيسية
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -120.67M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-41.18%
ROIC-40.68%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.00
Current Ratio12.60
Interest Coverage0.00
التقييم
P/E Ratio
-12.26
P/B Ratio6.15
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -134.22M |
| ROE | -41.18% | ROA | -46.06% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -120.67M |
| ROIC | -40.68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 12.60 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -12.26 | P/B Ratio | 6.15 |
| P/S Ratio | N/A | PEG Ratio | 1.31 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.65B | Enterprise Value | 1.37B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -134.22M | -100.88M | -76.33M | -42.73M | -29.62M |
| EPS (Diluted) | -2.48 | -2.63 | -2.27 | -1.41 | -0.85 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | -8,436.95 |
| Operating Income | -145.69M | -96.91M | -86.71M | -54.14M | -28.51M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 291.37M | 398.69M | 167.73M | 212.09M | 101.10M |
| Total Liabilities | 23.61M | 14.65M | 18.47M | 7.14M | 5.31M |
| Shareholders' Equity | 267.76M | 384.05M | 149.26M | 204.95M | 95.79M |
| Total Debt | 861,470.0 | 238,905.0 | 436,822.0 | 250,184.0 | 0.0 |
| Cash & Equivalents | 280.73M | 391.23M | 161.84M | 209.35M | 98.63M |
| Current Assets | 289.42M | 397.85M | 166.85M | 211.57M | 100.95M |
| Current Liabilities | 22.97M | 14.60M | 18.22M | 6.99M | 5.31M |